ATE107509T1 - Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren. - Google Patents

Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren.

Info

Publication number
ATE107509T1
ATE107509T1 AT86900528T AT86900528T ATE107509T1 AT E107509 T1 ATE107509 T1 AT E107509T1 AT 86900528 T AT86900528 T AT 86900528T AT 86900528 T AT86900528 T AT 86900528T AT E107509 T1 ATE107509 T1 AT E107509T1
Authority
AT
Austria
Prior art keywords
udpg
treatment
tumors
antitumors
composition
Prior art date
Application number
AT86900528T
Other languages
English (en)
Inventor
M Earl Balis
Original Assignee
Memorial Hospital Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Hospital Cancer filed Critical Memorial Hospital Cancer
Application granted granted Critical
Publication of ATE107509T1 publication Critical patent/ATE107509T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86900528T 1984-12-20 1985-12-17 Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren. ATE107509T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68387384A 1984-12-20 1984-12-20

Publications (1)

Publication Number Publication Date
ATE107509T1 true ATE107509T1 (de) 1994-07-15

Family

ID=24745804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86900528T ATE107509T1 (de) 1984-12-20 1985-12-17 Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren.

Country Status (9)

Country Link
EP (1) EP0205586B1 (de)
JP (2) JPH0660103B2 (de)
AT (1) ATE107509T1 (de)
AU (1) AU586220B2 (de)
DE (1) DE3587865T2 (de)
DK (1) DK379886A (de)
NZ (1) NZ214616A (de)
WO (1) WO1986003678A1 (de)
ZA (1) ZA859740B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA918336B (en) * 1990-10-19 1992-06-24 Boehringer Mannheim Italia Udpg as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without bau
WO1993013779A2 (en) * 1991-12-16 1993-07-22 Boehringer Mannheim Italia S.P.A. Use of udpg as cancer therapy rescue agent
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
US6683060B2 (en) * 2002-02-25 2004-01-27 Advanced Gene Technology Corp. Matrix metalloproteinase and tumor necrosis factor inhibitors
WO2007057440A2 (en) * 2005-11-17 2007-05-24 Innate Pharma Improved methods of using phosphoantigen for the treatment of cancer
WO2008059052A1 (en) * 2006-11-17 2008-05-22 Innate Pharma Improved methods of using phosphoantigen for the treatment of cancer
CN112129938B (zh) * 2019-06-25 2023-08-18 中国科学院分子细胞科学卓越创新中心 UDP-Glc在肺癌转移评估中的应用
CN111067868B (zh) * 2019-12-20 2021-12-21 湖北盛齐安生物科技股份有限公司 一种载药囊泡

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1239700A (de) * 1969-01-17 1971-07-21
DE2016049C3 (de) * 1970-04-03 1975-09-11 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von Nucleosiddiphosphaten bzw. ihren Estern
US3725201A (en) * 1971-09-08 1973-04-03 Marukin Shoyu Kk Manufacture of uridine-5-diphosphoglucuronic acid

Also Published As

Publication number Publication date
EP0205586A1 (de) 1986-12-30
WO1986003678A1 (en) 1986-07-03
JPS61501010A (ja) 1986-05-22
ZA859740B (en) 1986-07-30
DE3587865D1 (de) 1994-07-28
JPH0660103B2 (ja) 1994-08-10
AU5312586A (en) 1986-07-22
NZ214616A (en) 1989-04-26
DK379886D0 (da) 1986-08-08
DE3587865T2 (de) 1994-09-29
EP0205586B1 (de) 1994-06-22
JPS62501704A (ja) 1987-07-09
AU586220B2 (en) 1989-07-06
DK379886A (da) 1986-08-08
EP0205586A4 (de) 1990-01-08

Similar Documents

Publication Publication Date Title
ATE296309T1 (de) Wasserlösliche adenosin kinase inhibitoren
EP0957903A4 (de) Pharmazeutische zubereitungen und verfahren
DK0708772T3 (da) Imidazo[4,5,-c]pyridin-4-aminer
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
BR9911612A (pt) Composições de pirrolo[2,3d]pirimidina e seus usos
ATE282628T1 (de) Oral aktive adenosinkinase-inhibitoren
AP9100310A0 (en) Tnf inhibitors
ATE238047T1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
DE3587865D1 (de) Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren.
NO954880L (no) Cytidin deaminase
IL58103A (en) Sila-substituted 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
ATE282627T1 (de) Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DE68900760D1 (de) Virushemmende nukleosidmischung.
SE8900835D0 (sv) Improvement in or relating to organic compounds
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
DE3575730D1 (de) Modifizierte adeninegruppe enthaltende sonde, ihre herstellung und verwendungen.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3879575D1 (de) Alpha-carotin zur wachstumshemmung von krebszellen.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
CH550203A (de) Verfahren zur herstellung von in c8-stellung modifizierten purinribofuranosid-3' :5'-cyclophosphaten und deren verwendung.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
BR8700693A (pt) Expelentes de microbios fitopatogenicos e composicao expelente de microbios fitopatogenicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee